---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-023707"
form_type: "8-K"
ticker: "ABCL"
cik: "0001703057"
company_name: "AbCellera Biologics Inc."
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:27:56.597842+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# AbCellera shareholders elect Hansen and Hayden as Class II directors at annual meeting

## Summary
- Carl G. Hansen re-elected with 140.1M for, 32.2M against; Michael Hayden elected with 147.0M for, 25.3M against.
- KPMG ratified as independent auditor for FY 2022: 202.0M for, 0.4M against, 10.7M abstain.
- Non-binding say-on-pay approved: 167.8M for, 4.4M against, 10.7M abstain.
- Advisory vote favored one-year frequency for future say-on-pay: 171.7M for one year.
- Total outstanding shares: 284.5M; broker non-votes of 30.2M on director and say-on-pay proposals.

## SEC filing metadata
- accession: 0001564590-22-023707
- form_type: 8-K
- ticker: ABCL
- cik: 0001703057
- company_name: AbCellera Biologics Inc.
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/0001564590-22-023707-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1703057/000156459022023707/abcl-8k_20220615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-023707
- JSON: https://secwatch.observer/filing/0001564590-22-023707.json
- Plain text: https://secwatch.observer/filing/0001564590-22-023707.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.